ARCTURUS THERAPEUTICS HOLDINGS INC. Foreign Currency Transaction Gain (Loss), Realized
ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) reported Foreign Currency Transaction Gain (Loss), Realized of -$8.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossRealized · last filed 2026-08-06
- ARCTURUS THERAPEUTICS HOLDINGS INC. foreign currency transaction gain (loss), realized for the quarter ending 2026-06-30 was -$7.00K.
- ARCTURUS THERAPEUTICS HOLDINGS INC. foreign currency transaction gain (loss), realized for the quarter ending 2026-03-31 was -$1.00K.
- ARCTURUS THERAPEUTICS HOLDINGS INC. foreign currency transaction gain (loss), realized for the quarter ending 2025-12-31 was -$63.00K, a 136.63% decline year-over-year.
- ARCTURUS THERAPEUTICS HOLDINGS INC. foreign currency transaction gain (loss), realized for the quarter ending 2025-09-30 was -$170.00K.
- ARCTURUS THERAPEUTICS HOLDINGS INC. foreign currency transaction gain (loss), realized for fiscal 2025 was -$382.00K.
- ARCTURUS THERAPEUTICS HOLDINGS INC. foreign currency transaction gain (loss), realized for fiscal 2024 was -$471.00K.
- ARCTURUS THERAPEUTICS HOLDINGS INC. foreign currency transaction gain (loss), realized for fiscal 2023 was -$90.00K.
- ARCTURUS THERAPEUTICS HOLDINGS INC. foreign currency transaction gain (loss), realized for fiscal 2022 was -$375.00K, a 164.99% decline from fiscal 2021.
| Period end | Foreign Currency Transaction Gain (Loss), Realized 3 month | Foreign Currency Transaction Gain (Loss), Realized 6 month | Foreign Currency Transaction Gain (Loss), Realized 9 month | Foreign Currency Transaction Gain (Loss), Realized 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$8.00K 10-Q · filed 2026-08-06 | -$71.00K derived: sum of 3 quarters · filed 2026-08-06 | -$241.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$1.00K 10-Q · filed 2026-05-07 | -$64.00K derived: sum of 2 quarters · filed 2026-05-07 | -$234.00K derived: sum of 3 quarters · filed 2026-05-07 | -$362.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$233.00K derived: sum of 2 quarters · filed 2026-03-03 | -$361.00K derived: sum of 3 quarters · filed 2026-08-06 | -$382.00K 10-K · filed 2026-03-03 |
| 2025-09-30 | -$170.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$298.00K derived: sum of 2 quarters · filed 2026-08-06 | -$319.00K 10-Q · filed 2025-11-12 | -$147.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$128.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$149.00K 10-Q · filed 2026-08-06 | $23.00K derived: sum of 3 quarters · filed 2026-08-06 | -$179.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$21.00K 10-Q · filed 2026-05-07 | $151.00K derived: sum of 2 quarters · filed 2026-05-07 | -$51.00K derived: sum of 3 quarters · filed 2026-05-07 | -$439.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $172.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$30.00K derived: sum of 2 quarters · filed 2026-03-03 | -$418.00K derived: sum of 3 quarters · filed 2026-03-03 | -$471.00K 10-K · filed 2026-03-03 |
| 2024-09-30 | -$202.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$590.00K derived: sum of 2 quarters · filed 2025-11-12 | -$643.00K 10-Q · filed 2025-11-12 | -$643.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-30 | -$388.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$441.00K 10-Q · filed 2025-08-11 | -$441.00K derived: sum of 3 quarters · filed 2026-03-03 | -$371.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-03-31 | -$53.00K 10-Q · filed 2025-05-12 | -$53.00K derived: sum of 2 quarters · filed 2026-03-03 | $17.00K derived: sum of 3 quarters · filed 2026-03-03 | $17.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $70.00K derived: sum of 2 quarters · filed 2026-03-03 | $70.00K derived: sum of 3 quarters · filed 2026-03-03 | -$90.00K 10-K · filed 2026-03-03 |
| 2023-09-30 | $70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $70.00K derived: sum of 2 quarters · filed 2024-11-07 | -$90.00K 10-Q · filed 2024-11-07 | -$3.44M derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$160.00K 10-Q · filed 2024-08-05 | -$3.51M derived: sum of 3 quarters · filed 2025-03-06 | -$1.95M derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-03-31 | -$160.00K 10-Q · filed 2024-05-08 | -$3.51M derived: sum of 2 quarters · filed 2025-03-06 | -$1.95M derived: sum of 3 quarters · filed 2025-03-06 | -$693.00K derived: sum of 4 quarters · filed 2025-03-06 |
| 2022-12-31 | -$3.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$1.78M derived: sum of 2 quarters · filed 2025-03-06 | -$533.00K derived: sum of 3 quarters · filed 2025-03-06 | -$375.00K 10-K · filed 2025-03-06 |
| 2022-09-30 | $1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $2.82M derived: sum of 2 quarters · filed 2023-11-14 | $2.98M 10-Q · filed 2023-11-14 | $2.63M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-06-30 | $1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $1.41M 10-Q · filed 2023-08-07 | $1.06M derived: sum of 3 quarters · filed 2024-03-14 | $1.57M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-03-31 | $158.00K 10-Q · filed 2023-05-09 | -$188.00K derived: sum of 2 quarters · filed 2024-03-14 | $318.00K derived: sum of 3 quarters · filed 2024-03-14 | $295.00K derived: sum of 4 quarters · filed 2024-03-14 |
| 2021-12-31 | -$346.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $160.00K derived: sum of 2 quarters · filed 2024-03-14 | $137.00K derived: sum of 3 quarters · filed 2024-03-14 | $577.00K 10-K · filed 2024-03-14 |
| 2021-09-30 | $506.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $483.00K derived: sum of 2 quarters · filed 2022-11-09 | $923.00K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | -$23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $417.00K 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $440.00K 10-Q · filed 2022-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |